Clorox (CLX) Tops Q3 EPS by 6c; Trims FY EPS Outlook, Sees Sales at Top End
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Clorox Reports Q3 Fiscal Year 2018 Results, Updates Fiscal Year 2018 Outlook
May 2, 2018 6:30 AM EDTOAKLAND, Calif., May 2, 2018 /PRNewswire/ --Â The Clorox Company (NYSE: CLX) reported sales growth of 3 percent and diluted net earnings per share from continuing operations (diluted EPS) of $1.37, an increase of 5 percent, for its third quarter of fiscal year 2018, which ended March 31, 2018.
"We delivered solid sales growth of 3 percent, with gains in all U.S. segments and in our International segment, behind our 2020 Strategy,"Â said Chairman and CEO Benno Dorer. "Notably, we delivered these results on top of 4 percent sales growth in the year-ago quarter. Our focus on providing superior value to consumers... More



